Results 111 to 120 of about 42,464 (273)

Sildenafil helps the beat go on

open access: yes
Experimental Physiology, EarlyView.
Jules C. Hancox
wiley   +1 more source

The Use of Treprostinil for Bronchopulmonary Dysplasia Associated Pulmonary Hypertension

open access: yesPediatric Pulmonology, Volume 61, Issue 1, January 2026.
ABSTRACT Background Treprostinil for the treatment of bronchopulmonary dysplasia‐associated pulmonary hypertension (BPD‐PH) has previously been described in small cohort studies, often used later in the course after failure to improve on other therapies.
Stephanie M. Tsoi   +8 more
wiley   +1 more source

Sotatercept in Pulmonary Langerhans Cell Histiocytosis‐Associated Pulmonary Hypertension: A Case Series and Systematic Review

open access: yesPulmonary Circulation, Volume 16, Issue 1, January 2026.
ABSTRACT Pulmonary Langerhans cell histiocytosis (PLCH) frequently complicated by pulmonary hypertension (PH), which markedly worsens prognosis. We retrospectively reviewed three institutional PLCH‐PH cases treated with off‐label Sotatercept added to background triple therapy and performed a systematic review of published PLCH‐PH reports (PubMed/Embase
Giorgi Chilingarashvili   +7 more
wiley   +1 more source

Sildenafil dilates ophthalmic artery in type 2 diabetic patients

open access: yesSAGE Open Medicine, 2013
Background: Conflicting reports exist on the effect of sildenafil on ophthalmic artery blood flow; many visual disturbances due to vascular insult were reported with the use of sildenafil in diabetic patients like nonarteritic ischemic optic neuropathy ...
Akeel AMH Zwain   +2 more
doaj   +1 more source

Knowledge Gaps and Controversies on Cardiopulmonary Exercise Testing in the Assessment of Pulmonary Vascular Disease: An Official Statement of the Pulmonary Vascular Research Institute Exercise and Right Ventricular Function Task Force

open access: yesPulmonary Circulation, Volume 16, Issue 1, January 2026.
ABSTRACT Exercise testing has long been essential for evaluating diagnosis, prognosis, and functional status in pulmonary hypertension (PH). Recent advances have clarified its role in defining reference values and prognostic markers. Nonetheless, substantial knowledge gaps persist regarding the implementation of invasive cardiopulmonary exercise ...
Aaron B. Waxman   +20 more
wiley   +1 more source

Prognostic Value of Acute Vasoreactivity in Chronic Thromboembolic Pulmonary Hypertension

open access: yesPulmonary Circulation, Volume 16, Issue 1, January 2026.
ABSTRACT Vasoreactivity, which refers to the reduction of mean pulmonary arterial pressure in response to inhaled vasodilators, is a well‐established metric for prognostication and treatment selection in patients with pulmonary arterial hypertension. However, the role of vasoreactivity in chronic thromboembolic pulmonary hypertension is less studied ...
Justin A. G. Uphus   +10 more
wiley   +1 more source

State of the Field: The History of Masculinities

open access: yesHistory, Volume 111, Issue 394, Page 5-29, January 2026.
Abstract This State of the Field article discusses how, when and why the history of masculinities has emerged since the 1980s, and why it continues to be an important research field today. The article begins with the field's multiple origin stories and then discusses its expansion in chronology, geography and theme, as well as newer directions for ...
ERICA L. FRASER
wiley   +1 more source

Human hypoxia models in aerospace medicine: Potential applications for human pharmacological research

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 1, Page 58-72, January 2026.
Aerospace medicine required controlled terrestrial models to investigate influences of altered atmosphere conditions, such as hypoxia, on human health and performance. These models could potentially be expanded to encompass disease conditions or treatment targets regulated through hypoxia or hypercapnia.
Titiaan E. Post   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy